Instrument Business Outlook Volume 33 - Issue 22

10 Mar 2025
Table of Contents
  • IBO’s 2024 Company of the Year: Twist Bioscience
  • New Private Sector Labs
  • Correction: Labguru
  • Executive Briefing
    • Illumina Updates Guidance as China Officially Bans Illumina Sequencer Sales
    • Thermo Fisher to Make $4.1 Billion Acquisition
    • Parse Agrees to Injunction
    • 908 Sells Bioprocessing Assets
    • Shareholder Challenges Quanterix Acquisition
    • Leica Buys Reagent Provider
    • Oxford Nanopore Announces Lay Offs
    • Revvity Wins Injunction
    • Promega Files Patent Infringement Suit
    • Water Quality Probe Company Sold
  • IBO Stock Indexes Impacted by Macroeconomic Concerns
    • Laboratory Instruments and Products Stock Index
    • Diversified Laboratory Stock Index
    • International Stocks
  • Market Profile: Windowless EDS
    • Leading Vendors
    • Largest Markets
    • Instrument Cost
  • Industry Watch
    • Government: NIH Indirect Costs Update
    • Semiconductors: 2024 Sales Show Major Gains
    • Clinical: MCED’s Progress
  • Region Watch
    • Egypt: New Universities
    • Spain: Biotech R&D
    • Europe: Science Funding
  • News
    • Broad-Based Company News
      • Company Announcements
    • Sequencing
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Spectroscopy
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
  • Bottom Line